start portlet menu bar

Προβολή διαδικτυακού περιεχομένου

Display portlet menu
end portlet menu bar

HIPRA launches the new single-dose presentation of ERAVAC® vaccine for companion rabbits

Filtered by {{cFt}} Πίσω στα νέα
Αρχική Νέα HIPRA launches the new single-dose presentation of ERAVAC® vaccine for companion rabbits

HIPRA launches the new single-dose presentation of ERAVAC® vaccine for companion rabbits


HIPRA is launching the new single dose presentation of ERAVAC®, the first monovalent vaccine to be registered in Europe for the prevention of rabbit haemorrhagic disease type 2 (RHD-2).

This single-dose presentation has been authorized by the European Medicines Agency (EMA) with companion rabbits included in the indications as a target species.

ERAVAC® is an injectable emulsion ready for administration without the need for reconstitution beforehand. Containing 10 vials with individual doses, the new presentation is becoming the choice for active immunization of companion rabbits from 30 days of age.

With these variations, HIPRA reaffirms its commitment to the prevention of RHD-2 and demonstrates its support for the companion animals sector.

HIPRA will be present at the London Vet Show conference which is being held in London (England) on 15 and 16 December 2018

Μοιραστείτε